The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Arcus Biosciences Inc COM 03969F109 43,732 1,767,676 SH   OTR 1,2,3 0 1,767,676 0
Constellation Pharmceticls I COM 210373106 180,592 6,009,702 SH   OTR 3,4,5,6,7,8,9,10 0 6,009,702 0
Constellation Pharmceticls I COM 210373106 1,252 41,674 SH   OTR 3,8 0 41,674 0
Gritstone Oncology Inc COM 39868T105 11,294 1,700,945 SH   OTR 1,2,3 0 1,700,945 0
NGM Biopharmaceuticals Inc COM 62921N105 317,161 16,066,907 SH   OTR 1,2,3,4,5,6,7,8,9,10 0 16,066,907 0
NGM Biopharmaceuticals Inc COM 62921N105 32,375 1,640,071 SH   OTR 3,8 0 1,640,071 0
ORIC Pharmaceuticals Inc. COM 68622P109 160,831 4,768,181 SH   OTR 1,2,3 0 4,768,181 0
RAPT Therapeutics Inc COM 75382E109 195,222 6,727,151 SH   OTR 1,2,3,6,7,8,9,10 0 6,727,151 0
RAPT Therapeutics Inc COM 75382E109 1,451 50,000 SH   OTR 3 0 50,000 0
Revolution Medicines Inc COM 76155X100 43,252 1,370,022 SH   OTR 3,6,7,8,9,10 0 1,370,022 0
Revolution Medicines Inc COM 76155X100 208,594 6,607,362 SH   OTR 3,8 0 6,607,362 0